Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A. - Wikidata - wikimedia - TriplyDB

Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A.

Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A.

http://www.wikidata.org/entity/Q37307216

about

Current Perspectives in Autism Spectrum Disorder: From Genes to Therapy.Identification of new PDE9A isoforms and how their expression and subcellular compartmentalization in the brain change across the life span.

P2860

Q37444926-928D172B-7F75-414F-AB2A-A586AC3663B8 Q51765691-8F33757C-AFCD-4A05-8C18-A1C03D7D52E6

P2860

Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A.

http://www.wikidata.org/entity/Q37307216

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Reversal of neurobehavioral so ...... hodiesterases PDE5A and PDE9A.

@en

Reversal of neurobehavioral so ...... hodiesterases PDE5A and PDE9A.

@nl

type

label

Reversal of neurobehavioral so ...... hodiesterases PDE5A and PDE9A.

@en

Reversal of neurobehavioral so ...... hodiesterases PDE5A and PDE9A.

@nl

prefLabel

Reversal of neurobehavioral so ...... hodiesterases PDE5A and PDE9A.

@en

Reversal of neurobehavioral so ...... hodiesterases PDE5A and PDE9A.

@nl

P1433

Q37307216-E72BABE6-40B6-427E-9E23-01F8A770743C

P1476

Q37307216-C9BA358C-1232-42CF-BFCA-8036F3E2E31C

P2093

Q37307216-1BB7A571-BF1D-4DE0-A597-75AE5F2B8749

Q37307216-200831FE-890A-4C50-89E6-37938EC6E2BE

Q37307216-4BAA86C4-B55A-4D5C-937F-2B28441B6E4C

Q37307216-5400BBE0-FFED-4890-8FDD-A4EAE07DC138

Q37307216-5C5F17CC-E49D-40B5-BFAD-A74D3E41F677

Q37307216-6B278B03-008C-4F27-8FFB-9547D57EB54D

Q37307216-72CCE52B-D551-4D32-B8B2-DF94EC3EFDEB

Q37307216-7E89E066-71BA-460B-9B46-0F712778D2DC

Q37307216-9E4F518E-4D18-477F-8204-26B2E28C5549

Q37307216-B16947DB-AFE9-4243-9485-703EF3AAE81B

P2860

Q37307216-031C60C3-6BD2-4451-8108-92251C1E65B8

Q37307216-04FED346-182B-4F41-BE4D-DFC45C5424CE

Q37307216-0A2514DB-3284-46E2-9B8D-62986134E990

Q37307216-0AA30E8C-394F-4F52-8790-7BFA9D5FAB4B

Q37307216-0ACEEC12-7413-43BA-98AE-D27902D7EE29

Q37307216-0E3F15B9-1465-46BC-9558-EBE20CEB8B16

Q37307216-13A10A83-F00C-4C7F-91C4-7141AB784168

Q37307216-15FB2F10-D44E-4698-9EEB-E571E2422B4C

Q37307216-1F187C6D-9549-40E4-95A1-B5D0CFA15572

Q37307216-232C4E19-E9B6-439D-B4C0-15BD592551F0

P2888

Q37307216-16D86C94-0C33-4A28-BFBF-25FF7B755E5B

P304

Q37307216-2F2B4D3F-6424-4B06-AB42-271B4AF6A357

P31

Q37307216-711A0209-4EAA-4ACC-ADC6-831EC277FCDB

P356

Q37307216-167581F2-9B87-4C4F-9A8C-F5E9E977A8B9

P433

Q37307216-081CD52B-27E2-474C-ADD0-2DDB95970EA7

P478

Q37307216-4767B3C6-D6B0-4D50-809B-97318479B9A4

P50

Q37307216-A4D0F661-13C1-4A16-8230-7B3A6DA6959A

Q37307216-EE79B9FF-2A8D-4685-9DAE-C8821F9D4233

P577

Q37307216-DDB4B925-8477-4744-8137-B7B73631E563

P698

Q37307216-6F60B578-C9E3-4EC8-865F-3618111D3246

P932

Q37307216-F5580619-9087-44F0-9F38-6987C3EE49CB

P356

P1433

Translational Psychiatry

P1476

Reversal of neurobehavioral so ...... phodiesterases PDE5A and PDE9A

@en

P2093

C A Morris

http://www.w3.org/2001/XMLSchema#string

C J Schmidt

http://www.w3.org/2001/XMLSchema#string

D E Gibbs

http://www.w3.org/2001/XMLSchema#string

E L P Chekler

http://www.w3.org/2001/XMLSchema#string

J F Harms

http://www.w3.org/2001/XMLSchema#string

J L Marshall

http://www.w3.org/2001/XMLSchema#string

J M Spinazzola

http://www.w3.org/2001/XMLSchema#string

L M Kunkel

http://www.w3.org/2001/XMLSchema#string

M J Gasperini

http://www.w3.org/2001/XMLSchema#string

M S Alexander

http://www.w3.org/2001/XMLSchema#string

P2860

The electroretinographic diagnosis of the incomplete form of congenital stationary night blindness

Application of structure-based drug design and parallel chemistry to identify selective, brain penetrant, in vivo active phosphodiesterase 9A inhibitors

AMPAKINE enhancement of social interaction in the BTBR mouse model of autism

Altered social behavior and ultrasonic communication in the dystrophin-deficient mdx mouse model of Duchenne muscular dystrophy.

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

Automated three-chambered social approach task for mice

Pre-clinical models of neurodevelopmental disorders: focus on the cerebellum

Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice.

Drug screening in a zebrafish model of Duchenne muscular dystrophy.

PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy.

P2888

P304

e901

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/TP.2016.174

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27676442

http://www.w3.org/2001/XMLSchema#string

P932

5048211

http://www.w3.org/2001/XMLSchema#string